Genomic Vision (FRA:G09) Interest Expense : €-1.88 Mil (TTM As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Genomic Vision Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Genomic Vision's interest expense for the six months ended in Jun. 2023 was € -1.25 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-1.88 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Genomic Vision's Operating Income for the six months ended in Jun. 2023 was € -5.29 Mil. Genomic Vision's Interest Expense for the six months ended in Jun. 2023 was € -1.25 Mil. Genomic Vision did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Genomic Vision Interest Expense Historical Data

The historical data trend for Genomic Vision's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Interest Expense Chart

Genomic Vision Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.07

-0.68

Genomic Vision Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial															-0.05	-0.02	-0.05	-0.63	-1.25

Genomic Vision Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.88 Mil.

Genomic Vision (FRA:G09) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Genomic Vision's Interest Expense for the six months ended in Jun. 2023 was €-1.25 Mil. Its Operating Income for the six months ended in Jun. 2023 was €-5.29 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was €0.79 Mil.

Genomic Vision's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Genomic Vision did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Genomic Vision (FRA:G09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (FRA:G09) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220

Website

http://www.genomicvision.com

Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.

Genomic Vision (FRA:G09) Headlines

No Headlines